Clinical Trials Browser

Phase NA × Biological Therapy × Clear all

Carcinoma, Non-Small-Cell Lung

NCT01872819 2018-07-11

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay

Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

Clinical Trials

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay